Retrospective Analysis of Viral Hepatitis B Incidence in Russia from 2013 to 2017 in the Context of Preventive Vaccination
Open Access
- 20 December 2018
- journal article
- Published by SCEEMP in Biological Products. Prevention, Diagnosis, Treatment
- Vol. 18 (4) , 225-235
Abstract
The article presents the results of a retrospective analysis of viral hepatitis B incidence in the Russian Federation from 2013 to 2017, taking into account the use of vaccines included into the National Immunisation Schedule and the Immunisation Programme in Case of Epidemic Outbreaks. The analysis of the data revealed a trend towards a reduction in the incidence of acute and chronic forms of hepatitis B in the territory of the Russian Federation during the past five years. The reduction of viral hepatitis B incidence was achieved thanks to a higher vaccination coverage of both children and adults. The article presents an overview of monovalent and combination recombinant hepatitis B vaccines licensed in the Russian Federation. It describes the WHO position on preventive vaccination against viral hepatitis B, and pays special attention to vaccination of people at risk. The article considers promising areas for improving immunobiological products for hepatitis B prevention, including new technologies used in vaccine production, development and introduction of new adjuvants or adjuvants systems, and development of therapeutic vaccines.Keywords
This publication has 26 references indexed in Scilit:
- Hepatitis B Vaccines2018
- Impact of Universal Hepatitis B Vaccination on Prevalence, Infection-Associated Morbidity and Mortality, and Circulation of Immune Escape Variants in RussiaPLOS ONE, 2016
- The clinical implications of hepatitis B virus genotypes and HBeAg in pediatricsReviews in Medical Virology, 2016
- Vaccinoprophylaxis of Hepatitis B N.AEpidemiology and Vaccinal Prevention, 2015
- Birth order and risk of hepatocellular carcinoma in chronic carriers of hepatitis B virus: a case–control study in The GambiaLiver International, 2015
- Hepatitis B virus genotypes: Global distribution and clinical importanceWorld Journal of Gastroenterology, 2014
- Long-term protection of neonatal hepatitis B vaccination in a 30-year cohort in Hong KongJournal of Hepatology, 2013
- The Global Epidemiology of Hepatocellular Carcinoma: Present and FutureClinics in Liver Disease, 2011
- Hepatitis B surface antigen (HBsAg) derived from yeast cells (Hansenula polymorpha) used to establish an influence of antigenic subtype (adw2, adr, ayw3) in measuring the immune response after vaccinationVaccine, 2002
- Viral hepatitis: a pathologic spectrumThe American Journal of the Medical Sciences, 1975